7.2. Treatment of vaginal and vulval conditions
7.2.1. Preparations for vaginal and vulval changes
Restrictions:
Treatment of moderate to severe symptomatic vulvar and vaginal atrophy (VVA) in post-menopausal women who are not candidates for local vaginal oestrogen therapy is restricted to intitiation by, or on advice of, a specialist.
Prescribing Notes:
The estriol concentration of estriol intravaginal cream is 0.01%. This preparation contains arachis (peanut) oil and is not suitable for patient with peanut allergy. This preparation also damages latex condoms. Ovestin intravaginal cream is 0.1% and does not contain arachis oil.
7.2.2. Vaginal and vulval infections
Restrictions:
The treatment of bacterial vaginosis is restricted to use in patients for whom the initial treatment is not effective or well tolerated.
Restrictions:
Metronidazole gel is restricted to patients unable to tolerate or comply with oral metronidazole therapy.
Prescribing Notes:
Strength: 0.75%